| On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models H Cho, X Du, JP Rizzi, E Liberzon, AA Chakraborty, W Gao, I Carvo, ... Nature 539 (7627), 107-111, 2016 | 429 | 2016 |
| PD-L1 expression in nonclear-cell renal cell carcinoma TK Choueiri, AP Fay, KP Gray, M Callea, TH Ho, L Albiges, J Bellmunt, ... Annals of oncology 25 (11), 2178-2184, 2014 | 326 | 2014 |
| Differential expression of PD-L1 between primary and metastatic sites in clear-cell renal cell carcinoma M Callea, L Albiges, M Gupta, SC Cheng, EM Genega, AP Fay, J Song, ... Cancer immunology research 3 (10), 1158-1164, 2015 | 280 | 2015 |
| Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study AP Fay, S Signoretti, M Callea, GH Telό, RR McKay, J Song, I Carvo, ... Journal for immunotherapy of cancer 3, 1-8, 2015 | 97 | 2015 |
| Tumor vascularity in renal masses: correlation of arterial spin-labeled and dynamic contrast-enhanced magnetic resonance imaging assessments Y Zhang, P Kapur, Q Yuan, Y Xi, I Carvo, S Signoretti, I Dimitrov, ... Clinical genitourinary cancer 14 (1), e25-e36, 2016 | 54 | 2016 |
| Differential expression of PD-L1 between primary and metastatic sites in clear-cell renal cell carcinoma. Cancer Immunol. Res. 2015; 3: 1158–1164. doi: 10.1158/2326-6066 M Callea, L Albiges, M Gupta, SC Cheng, EM Genega, AP Fay, J Song, ... External Resources Pubmed/Medline (NLM) Crossref (DOI), 0 | 40 | |
| Oral immune‐related adverse events associated with PD‐1 inhibitor therapy: A case series MA Shazib, SB Woo, H Sroussi, I Carvo, N Treister, A Farag, J Schoenfeld, ... Oral Diseases 26 (2), 325-333, 2020 | 37 | 2020 |
| Intratumor heterogeneity of perfusion and diffusion in clear-cell renal cell carcinoma: correlation with tumor cellularity Q Yuan, P Kapur, Y Zhang, Y Xi, I Carvo, S Signoretti, IE Dimitrov, ... Clinical genitourinary cancer 14 (6), e585-e594, 2016 | 37 | 2016 |
| PD-L1 expression in primary clear cell renal cell carcinomas (ccRCCs) and their metastases. M Callea, EM Genega, M Gupta, SC Cheng, AP Fay, J Song, I Carvo, ... Journal of Clinical Oncology 32 (15_suppl), 4585-4585, 2014 | 34 | 2014 |
| Young investigator challenge: application of cytologic techniques to circulating tumor cell specimens: detecting activation of the oncogenic transcription factor STAT3 AC Lowe, JC Pignon, I Carvo, MG Drage, NM Constantine, N Jones, ... Cancer Cytopathology 123 (12), 696-706, 2015 | 19 | 2015 |
| Architectural alterations in oral epithelial dysplasia are similar in unifocal and proliferative leukoplakia CC Li, S Almazrooa, I Carvo, A Salcines, SB Woo Head and neck pathology 15, 443-460, 2021 | 16 | 2021 |
| Differential expression of PD-L1 between primary and metastatic sites in clear-cell renal cell carcinoma. Cancer Immunol Res. 2015; 3 (10): 1158–64 M Callea, L Albiges, M Gupta, SC Cheng, EM Genega, AP Fay, J Song, ... doi. org/10.1158/2326-6066. cir-15-0043, 0 | 15 | |
| PD-L1 expression in non-clear cell renal cell carcinoma. AP Fay, M Callea, KP Gray, TH Ho, J Song, I Carvo, ME Lampron, ... Journal of Clinical Oncology 32 (4_suppl), 424-424, 2014 | 14* | 2014 |
| Phase 2 study of bevacizumab and temsirolimus after VEGFR TKI in metastatic renal cell carcinoma KM Mahoney, S Jacobus, RS Bhatt, J Song, I Carvo, SC Cheng, ... Clinical Genitourinary Cancer 14 (4), 304-313. e6, 2016 | 10 | 2016 |
| PD-L1 expression in non-clear cell renal cell carcinoma. AP Fay, M Callea, KP Gray, TH Ho, J Song, I Carvo, ME Lampron, ... Journal of Clinical Oncology 32 (4_suppl), 424-424, 2014 | 10 | 2014 |
| Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostate JC Pignon, C Grisanzio, I Carvo, L Werner, M Regan, EL Wilson, ... PLoS One 10 (5), e0128489, 2015 | 7 | 2015 |
| MP11-14 QUANTITATIVE PERFUSION MEASUREMENTS IN RENAL MASSES WITH ASL AND DCE MRI AT 3T CORRELATE WITH MICROVASCULAR DENSITY AT HISTOPATHOLOGY Y Zhang, P Kapur, Q Yuan, A Madhuranthakam, I Carvo, S Signoretti, ... The Journal of Urology 193 (4S), e124-e124, 2015 | | 2015 |
| Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study TK Choueiri, A Elfiky, GJ Freeman, FS Hodi, J Bellmunt, ... | | 2015 |
| Quantitative Perfusion Measurements in Renal Masses with Arterial Spin Labeling and Dynamic Contrast Enhanced MRI at 3T Correlate with Microvessel Density at Histopathology Y Zhang, P Kapur, Q Yuan, A Madhuranthakam, I Carvo, S Signoretti, ... Proc. Intl. Soc. Mag. Reson. Med 23, 0670, 2015 | | 2015 |
| Dynamic Contrast Enhanced MRI Detection of a Central Defect in Clear Cell Renal Cell Carcinoma Correlates with a Tumor Scar and Lower Tumor Proliferation Rate Y Zhang, P Kapur, Q Yuan, A Madhuranthakam, I Carvo, S Signoretti, ... Proc. Intl. Soc. Mag. Reson. Med 23, 3875, 2015 | | 2015 |
